Research programme: optide diagnostic imaging agents - Blaze Bioscience
Alternative Names: Optides-Blaze Bioscience; Tumour Paint™Latest Information Update: 16 Jul 2016
At a glance
- Originator Blaze Bioscience
- Class Imaging agents; Peptide diagnostics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours(Diagnosis) in USA
- 18 Oct 2011 Preclinical trials in Solid tumours (diagnosis) in USA (unspecified route)